2. Names index numbers
ABOTSI JOSEPH K. UHAS20178634
BRAYIE CECELIA UHAS20173327
ADU-DICKSON JULIET UHAS20178114
STEPHEN ANANE UHAS20177601
3. OBJECTIVES
INTRODUCTION
BACKROUND AND HISTORY
PATHOPHYSIOLOGY/DISEASE MECHANISM
CLINICAL SIGNS AND SYMPTOMS
DIAGNOSIS AND TECHNOLOGY
TREATMENT APPROACHES
4. Introduction
What is amyotrophic lateral sclerosis?
"a" for without
"myo" for muscle
"trophic" for nourishment
"lateral" for side (of the spinal cord)
"sclerosis" for hardening or scarring
It’s a fatal disease of nervous system, characterized by
progressive muscle weakness resulting in paralysis.
MOST LIFE PATTERN OF THIS PATIENT IS BETWEEEN 2-5 YEARS
5. Definition
Amyotrophic Lateral Sclerosis Pathology
◆ Degeneration and death of motor nerves
1. Upper Motor Neuron
– within brain/spinal cord
2. Lower Motor Neurons
– leaves brain (stem)/spinal cord
◆ Relatively spared
• Eye movements and bowel/bladder function
6. Background and history
ALS also known as Lou Gehrig’s Disease or Motor Neuron
Disease (MND).
ALS was first described in 1869 by Jean-Martin Charcot, a
French neurologist.
And was brought to national attention once baseball
legend, Lou Gehrig was diagnosed with the disease in
1939
7.
8. Cause and disease mechanism
:
•Genetic Factor.
-- 20% are linked to a mutation in the SOD1 gene
-- Only a small amount is linked with mutant gene
•Glutamate:
when found in excess it builds up and causes an overflow of calcium into
motor neurons. This eventually leads to destruction of nerve
cells.
•environmental factors :such as heavy metal exposure leads to damage nerve.
•Viral infections: are yet another factor that may play a role in
the development of ALS.
•Free Radical
11. Clinical signs and symptoms
Dysphagia:
Weakness in Muscles:
Slurred Speech
Losing Control over Laughing and Crying
Muscle Cramps
Loss of Balance
Overall Weakness and Fatigue
Breathing difficulties
12. Bulbar Als Onset
•Condition where the disorder strikes the tongue rather than limbs
•Pons and medulla area of brain stem was known the or bulbar area of the brain
•The nerves on the facial region that are connected with the bulb region of the brain
controls Throat, jaw, tongue and face
Q) What are Bulbar ALS problems?
1. Slurred speech
2. difficulty in swallowing and chewing food etc
13. Diagnosis and technology
Normally in the diagnosis of this condition three main studies are being considered
1. Nerve conduction studies
• assess for demyelinating vs. axonal involvement
2. Electromyography
• confirm ALS
• myopathy
3. MRI cervical spine
• Cervical Spondylosis with cord compression
• Herniated disc
Differential diagnosis
I. Dementia - < 5 %
◆ Sensory loss – atypical
◆ 25% complain of paresthesias
◆ Oculomotor dysfunction
◆ Bowel or bladder dysfunction
14. PHYSIOTHERAPY INTERVENTION
Treatment is mostly considered from the MDT approach.
Physical therapy that is tailored to the individual’s needs and goals and focused on
addressing symptoms and maximizing function and participation enables people with
ALS to live their lives to the fullest and with quality.
TREATMENT GOALS
Improving function and providing instruction on managing physical disabilities.
Recommending appropriate exercises to maintain flexibility, while preventing and
reducing physical pain.
Providing instruction regarding the use of assistive devices, braces or other mobility
aids to maximize independence.
15. Treatment
1. Aerobic exercises in moderate
To help increase cardiovascular fitness ,heart rate etc
2. Stretching exercises(active and passive)
May help decrease the frequency or intensity of muscle cramping.
3. Range of motion exercises
This is to help reduce stiffness at the joint.
4. Strengthening exercises
5. Prescribing appropriate equipment, which helps with functional independence within
areas of occupation. Eg canes, wheelchairs, braces such as foot-ankle braces.
16. Reference
Aebischer, P., & Kato, A. C. (2007). Playing defense against Lou Gehrig’s disease. Scientific
American, 297(5), 86-93. Retrieved from EBSCOhost.
American Occupational Therapy Association. (2008). Occupational therapy practice
framework: Domain and Process (2nd ed.). American Journal of Occupational Therapy, 62,
625-683
Atchison, B. J., & Dirette, D. K. (2007). Conditions in Occupational Therapy (3rd ed., pp.
268-271). Baltimore, MD: Lippincott Williams & Wilkins.
Bento-Abreu, A., Van Damme, P., Van Den Bosch, L., & Robberecht, W. (2010). The
neurobiology of amyotrophic lateral sclerosis. European Journal of Neuroscience, 31(12),
2247-2265. doi:10.1111/j.1460-9568.2010.07260.x
Corcia, P., & Meininger, V. (2008). Management of amyotrophic lateral sclerosis. Drugs,
68(8), 1037-1048. Retrieved from EBSCOhost